Traustadttir T, Harman SM, Tsitouras P, Pencina KM, Li Z, Travison TG, et al
GLP-1 medications strengthen the intestinal barrier and improve gut dysbiosis patterns, reducing bacterial endotoxin translocation
The most common side effects are digestive, including nausea, vomiting, and reduced appetite
Many effective products combine both ingredients for enhanced results
Genome-wide association studies (GWAS) in humans show that the GIPR locus contributes to body weight (BW) regulation and GIPR knockout mice are protected from diet-induced obesity (DIO) 27,28,29,30,31,32
Histological assessment revealed alcoholic liver steatosis and fibrosis were confirmed in the AF cohort where there was an increased steatosis score and fibrosis percentage compared to both PF and AF + P (Supplementary Fig